|
FAM104A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.30509999999962E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.023640E-04 |
| Normal-vs-Stage2 |
3.458100E-02 |
| Normal-vs-Stage3 |
3.68090000000265E-05 |
| Normal-vs-Stage4 |
7.579500E-04 |
| Stage1-vs-Stage2 |
4.463600E-01 |
| Stage1-vs-Stage3 |
4.440800E-01 |
| Stage1-vs-Stage4 |
6.379800E-01 |
| Stage2-vs-Stage3 |
2.663200E-01 |
| Stage2-vs-Stage4 |
3.658600E-01 |
| Stage3-vs-Stage4 |
8.801200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4904999999964E-05 |
| Normal-vs-AfricanAmerican |
1.181530E-02 |
| Normal-vs-Asian |
3.744600E-03 |
| Caucasian-vs-AfricanAmerican |
5.085600E-01 |
| Caucasian-vs-Asian |
1.290610E-01 |
| AfricanAmerican-vs-Asian |
7.744200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.976410E-04 |
| Normal-vs-Female |
1.54817999999945E-05 |
| Male-vs-Female |
3.496600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.414500E-02 |
| Normal-vs-Age(41-60Yrs) |
8.16030000000412E-05 |
| Normal-vs-Age(61-80Yrs) |
5.9311999999978E-05 |
| Normal-vs-Age(81-100Yrs) |
6.501800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.578800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.898600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.777800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.044200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.045800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.379200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.62320999999022E-05 |
| Normal-vs-Grade 2 |
2.03069999999972E-05 |
| Normal-vs-Grade 3 |
1.624780E-03 |
| Normal-vs-Grade 4 |
1.67605999999987E-05 |
| Grade 1-vs-Grade 2 |
1.539380E-01 |
| Grade 1-vs-Grade 3 |
4.101500E-03 |
| Grade 1-vs-Grade 4 |
9.749000E-01 |
| Grade 2-vs-Grade 3 |
1.624360E-02 |
| Grade 2-vs-Grade 4 |
1.585450E-01 |
| Grade 3-vs-Grade 4 |
4.875500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.09290000000074E-05 |
| Normal-vs-ccB subtype |
6.3543999999971E-05 |
| ccA subtype-vs-ccB subtype |
4.533800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.404100E-04 |
| Normal-vs-N1 |
1.278310E-03 |
| N0-vs-N1 |
1.162810E-01 |
|
|
